Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-15

Clinical Trial Update: Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing oral liposomal iron with injectable iron sucrose for anemia in non-dialysis chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iron sucrose (iron sucrose)
  • Oral liposomal iron (liposomal iron)

Snippet

Sponsor: Centre Hospitalier Hassan II - Fès | Conditions: Anemia of Chronic Kidney Disease | Phase 4 | Status: COMPLETED